Exact Mass: 279.0259
Exact Mass Matches: 279.0259
Found 201 metabolites which its exact mass value is equals to given mass value 279.0259,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Cidofovir
Cidofovir is only found in individuals that have used or taken this drug. It is an injectable antiviral medication for the treatment of cytomegalovirus (CMV) retinitis in patients with AIDS. It suppresses CMV replication by selective inhibition of viral DNA synthesis. [Wikipedia]Cidofovir acts through the selective inhibition of viral DNA polymerase.Biochemical data support selective inhibition of CMV DNA polymerase by cidofovir diphosphate, the active intracellular metabolite of cidofovir. Cidofovir diphosphate inhibits herpesvirus polymerases at concentrations that are 8- to 600-fold lower than those needed to inhibit human cellular DNA polymerase alpha, beta, and gamma(1,2,3). Incorporation of cidofovir into the growing viral DNA chain results in reductions in the rate of viral DNA synthesis. J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AB - Nucleosides and nucleotides excl. reverse transcriptase inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C471 - Enzyme Inhibitor > C29575 - DNA Polymerase Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent D004791 - Enzyme Inhibitors
N-[4'-hydroxy-(E)-cinnamoyl]-L-aspartic acid
N-[4-hydroxy-(E)-cinnamoyl]-L-aspartic acid is a cocoa metabolite from gut microflora. It is found n urine. Constituent of Arabidopsis thalianaand is also found in roasted cocoa beans and coffee powder [CCD].
7-Hydroxyticlopidine
7-Hydroxyticlopidine is a metabolite of Ticlopidine. 7-Hydroxyticlopidine belongs to the family of Thienopyridines. These are heterocyclic compounds containing a thiophene ring fused to a pyridine ring.
2-Oxoticlopidine
2-Oxoticlopidine is only found in individuals that have used or taken Ticlopidine. 2-Oxoticlopidine is a metabolite of Ticlopidine. 2-oxoticlopidine belongs to the family of Thienopyridines. These are heterocyclic compounds containing a thiophene ring fused to a pyridine ring.
Ticlopidine S-oxide
Ticlopidine S-oxide is only found in individuals that have used or taken Ticlopidine. Ticlopidine S-oxide is a metabolite of Ticlopidine. Ticlopidine s-oxide belongs to the family of Thienopyridines. These are heterocyclic compounds containing a thiophene ring fused to a pyridine ring.
Ticlopidine N-oxide
Ticlopidine N-oxide is a metabolite of ticlopidine. Ticlopidine (trade name Ticlid) is an antiplatelet drug in the thienopyridine family. Like clopidogrel, it is an adenosine diphosphate (ADP) receptor inhibitor. It is used in patients in whom aspirin is not tolerated, or in whom dual antiplatelet therapy is desirable. (Wikipedia)
(2R,4S)-2-Aminoformyl-6-fluoro-spiro[chroman-4,4'-imidazolidine]-2',5'-dione
2-(2,4-Dichloro-phenoxy)-N-(2-mercapto-ethyl)-acetamide
Fasentin
Fasentin, a potent glucose uptake inhibitor, inhibits GLUT-1/GLUT-4 transporters. Fasentin preferentially inhibits GLUT4 (IC50=68 μM) over GLUT1. Fasentin is a death receptor stimuli (FAS) sensitizer and sensitizes cells to FAS-induced cell death. Fasentin is also a tumor necrosis factor (TNF) apoptosis-inducing ligand sensitizer. Fasentin blocks glucose uptake in cancer cell lines and has anti-angiogenic activity[1][2][3].
Fexinidazole
P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01C - Agents against leishmaniasis and trypanosomiasis > P01CA - Nitroimidazole derivatives C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
Benzo(f)-1,3-benzodioxolo(6,5,4-cd)indol-5(6H)-one, 8-hydroxy-
3-(2-amino-4,6-dioxo-3,4,5,6-tetrahydro-pteridin-7-yl)-2-oxo-propionic acid methyl ester|Erythropterin-methylester
2-Chloro-7-ethyl-6,8-dihydroxy-9H-pyrrolo[2,1-b][1,3]benzoxazine-9-one
Aristololactam IIIa
Aristololactam IIIa is a natural product found in Aristolochia debilis, Aristolochia kaempferi, and other organisms with data available.
ZLJ-6
N-[4-hydroxy-(E)-cinnamoyl]-L-aspartic acid
3-chloro-5-(2-chloro-5-hydroxyphenoxy)benzonitrile
1-CYCLOPROPYL-6,7-DIFLUORO-5-METHYL-4-OXO-3-QUINOLINE CARBOXYLIC ACID
sodium [3-(5-chloro-2-methoxyphenyl)-1-methyl-2-triazeno]acetate
1-[3-chloro-5-(trifluoromethyl)-2-pyridyl]-1,4-diazepane
4-[2-(chloromethyl)-4-(trifluoromethyl)phenyl]morpholine
(2-amino-5-chlorophenyl)(2-fluoro-6-Methoxyphenyl)Methanone
2-(5-benzylidene-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl)acetic acid
6-BROMO-2-METHYL-QUINOLINE-4-CARBOXYLIC ACID METHYL ESTER
(s)-(+)-3-(benzyloxycarbonyl)-5-oxo-4-oxazolidineacetic acid
2-Propenoic acid, 2-cyano-3-(4-bromophenyl)-, ethyl ester
2-BROMO-1-(5-METHYL-3-PHENYLISOXAZOL-4-YL)ETHAN-1-ONE
4-[4-Chloro-3-(trifluoromethyl)phenyl]-4-piperidinol
3-(4-FLUOROPHENYL)-3-(2,2,2-TRIFLUOROACETAMIDO)PROPANOIC ACID
6-Benzyl-2,4-dichloro-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidine
2-Bromomethylmorpholine-4-carboxylic acid tert-butyl ester
(2-(BUTYLTHIO)-5-(TRIFLUOROMETHYL)PYRIDIN-3-YL)BORONIC ACID
2-(2,3-DIHYDRO-1-BENZOFURAN-5-YL)-4-METHYLTHIAZOLE-5-CARBONYLCHLORIDE
1-(3-Bromophenyl)-5-methyl-1H-pyrazole-3-carboxamide
2-(6-amino-1,3-benzothiazol-2-yl)-4,5-dihydro-1,3-thiazole-4-carboxylic acid
dimethylammonium 2-(2,4-dichlorophenoxy)propionate
3-benzylhydroxy-6-hydroxymethylpyridine-2-carboxaldehyde hydrochloride
(2-(ISOBUTYLTHIO)-5-(TRIFLUOROMETHYL)PYRIDIN-3-YL)BORONIC ACID
TPCA-1
D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors
4,7-Dichloro-8-methyl-2-(trifluoromethyl)quinoline
(R)-tert-Butyl 2-(bromomethyl)morpholine-4-carboxylate
(S)-tert-Butyl 2-(bromomethyl)morpholine-4-carboxylate
4-Chloro-6-ethoxyquinoline-3-carboxylic acid ethyl ester
4-Chloro-8-(methylsulfanyl)-6-nitro-3-quinolinecarbonitrile
Letosteine
R - Respiratory system > R05 - Cough and cold preparations > R05C - Expectorants, excl. combinations with cough suppressants > R05CB - Mucolytics C78273 - Agent Affecting Respiratory System > C74536 - Mucolytic Agent D019141 - Respiratory System Agents > D005100 - Expectorants
2-[(5-AMINO-1,3,4-THIADIAZOL-2-YL)THIO]-5-NITROBENZONITRILE
2-[1-(4-methylphenyl)sulfonylpyrrol-3-yl]acetic acid
(4-carbamoyl-3-hydroxy-isothiazol-5-yl)-carbamic acid phenyl ester
[5-furan-2-yl-4-(2-methyl-allyl)-4 h-[1,2,4]triazol-3-ylsulfanyl]-acetic acid
7-PHENYL-1-(PROP-2-YNYL)-1H-PYRIMIDO[4,5-D][1,3]OXAZINE-2,4-DIONE
1-(3-BROMOPROPYL)-2,2,5,5-TETRAMETHYL-1-AZA-2,5-DISILACYCLOPENTANE
6-Bromo-2-[(2R)-2-pyrrolidinylmethyl]-1H-pyrrolo[2,3-b]pyridine
6-Bromo-2-[(2S)-2-pyrrolidinylmethyl]-1H-pyrrolo[2,3-b]pyridine
Cytarabine hydrochloride
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D000890 - Anti-Infective Agents > D000998 - Antiviral Agents D009676 - Noxae > D000963 - Antimetabolites D000970 - Antineoplastic Agents Cytarabine hydrochloride, a nucleoside analog, causes S phase cell cycle arrest and inhibits DNA polymerase. Cytarabine inhibits DNA synthesis with an IC50 of 16 nM. Cytarabine hydrochloride has antiviral effects against HSV.
5-Bromo-2-[(2R)-2-pyrrolidinylmethyl]-1H-pyrrolo[2,3-b]pyridine
4-(4-fluorophenyl)sulfonylpiperidine,hydrochloride
4-anilino-6-chloro-2-methylsulfanylpyrimidine-5-carbaldehyde
(+/-)-8,9-Difluoro-5-methyl-6,7-dihydro-1-oxo-1H,5H-bnezo[i,j]quinolizine-2-carboxylic acid
ETHYL 8-CHLORO[1,3]DIOXOLO[4,5-G]QUINOLINE-7-CARBOXYLATE
7-BROMO-1,2,3,4-TETRAHYDRO-3-(TRIFLUOROMETHYL)-ISOQUINOLINE
5-(4-BROMO-PHENYL)-2-ISOPROPYL-2H-PYRAZOL-3-YLAMINE
2-(4-METHOXYBENZOYL)-3,3-DI(METHYLTHIO)ACRYLONITRILE
ETHYL 8-CHLORO-1-ETHYL-4-OXO-4H-QUINOLIZINE-3-CARBOXYLATE
methyl 1-cyclopropyl-6,7-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylate
2-Amino-5-beta-D-ribofuranosyl-4(1H)-pyrimidinone hydrochloride
7-Bromo-5-fluoro-2-methyl-1,2,3,4-tetrahydro-isoquinoline hydrochloride
Ethyl 2-amino-4-(4-fluorophenyl)-5-methyl-thiophene-3-carboxylate
3-Quinolinecarbonitrile,2-amino-6-chloro-4-phenyl-
3-(3-Fluoro-4-hydroxyphenyl)-7-hydroxy-1-naphthonitrile
3-chloro-2,2-dimethyl-N-[4-(trifluoromethyl)phenyl]propanamide
N-[2-chloro-5-(trifluoromethyl)phenyl]imidodicarbonimidic diamide
2-(2,4-Dichloro-phenoxy)-N-(2-mercapto-ethyl)-acetamide
Taribavirin hydrochloride
D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent
5-[(2-Chlorophenyl)methyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-7-ol
6-Fluoro-2,5-dioxo-2,3-dihydrospiro[chromene-4,4-imidazolidine]-2-carboxamide
[2-(2,3-Dimethoxyphenyl)-1,3-thiazol-4-yl]acetic acid
N-[5-(methylthio)-1,3,4-thiadiazol-2-yl]-3-phenylpropanamide
Dimethyl 2-[[bis(methylsulfanyl)methylideneamino]methyl]butanedioate
(2S,4R)-2-Aminoformyl-6-fluoro-spiro[chroman-4,4-imidazolidine]-2,5-dione
But-3-enyl-[5-(4-chloro-phenyl)-3,6-dihydro-[1,3,4]thiadiazin-2-ylidene]-amine
Fexinidazole
P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01C - Agents against leishmaniasis and trypanosomiasis > P01CA - Nitroimidazole derivatives C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
(4S)-2-(6-hydroxy-1,3-benzothiazol-2-yl)-4,5-dihydro-1,3-thiazole-4-carboxylate
(4R)-2-(6-hydroxy-1,3-benzothiazol-2-yl)-4,5-dihydro-1,3-thiazole-4-carboxylate
2-[4-(Trifluoromethoxy)phenyl]imidazo[1,2-a]pyrimidine
N-[5-(ethylthio)-1,3,4-thiadiazol-2-yl]-4-methylbenzamide
2-[(3-Methoxyphenyl)-oxomethyl]-3,3-bis(methylthio)-2-propenenitrile
4-amino-3-methyl-N-(phenylmethyl)-2-sulfanylidene-5-thiazolecarboxamide
O3-(3-chlorobenzoyl)-5-methylisoxazole-3-carbohydroximamide
2-(2-Chlorophenyl)-5-fluoro-1,2-benzothiazol-3-one
2-[2-(Butan-2-ylidene)hydrazino]-4-(4-chlorophenyl)-1,3-thiazole
2-Hydroxy-4-methoxybenzoic acid (2-methyl-4-thiazolyl)methyl ester
5-(4-Hydroxy-3-nitrobenzylidene)-3-methyl-2-thioxo-4-imidazolidinone
(5Z)-5-(1-naphthylmethylene)[1,3]thiazolo[3,2-b][1,2,4]triazol-6(5H)-one
3-Chloro-4-[(2-fluorophenyl)methoxy]benzaldehyde oxime
2-Chloro-3-(3-methoxypropylimino)naphthalene-1,4-dione
6-Chloro-3-(3,3-dimethyl-2-oxobutyl)-1,4-benzoxazin-2-one
6-Chloro-3-(4-methyl-2-oxopentyl)-1,4-benzoxazin-2-one
2-Chloro-4-quinolinecarboxylic acid trimethylsilyl ester
Cidofovir
J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AB - Nucleosides and nucleotides excl. reverse transcriptase inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C471 - Enzyme Inhibitor > C29575 - DNA Polymerase Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent D004791 - Enzyme Inhibitors
ent-Photinus luciferin(1-)
A monocarboxylic acid anion that is the conjugate base of ent-Photinus luciferin, obtained by deprotonation of the carboxy group; major species at pH 7.3.
7-Hydroxyticlopidine
A thienopyridine that is ticlopidine which carries a hydroxy group at position 7. It is a metabolite of the antiplatelet drug, ticlopidine.
6-bromoconicamin
A bromoindole that is 1H-indole substituted by 2-(trimethylazaniumyl)ethenyl and bromo groups at positions 3 and 6, respectively. It is isolated from the marine sponge Geodia barretti.
UCM-1306
UCM-1306 is a potent and orally active human dopamine D1 receptor allosteric modulator (PAM). UCM-1306 increases the endogenous dopamine (DA) maximal effect both in human and mouse D1 receptors. UCM-1306 is not only for improving motor symptoms but also for addressing the key comorbid cognitive impairment associated with long-term Parkinson’s disease (PD)[1].
aristolactam i; o-de-me
{"Ingredient_id": "HBIN016781","Ingredient_name": "aristolactam i; o-de-me","Alias": "NA","Ingredient_formula": "C16H9NO4","Ingredient_Smile": "NA","Ingredient_weight": "279.25","OB_score": "NA","CAS_id": "85814-30-8","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "6669","PubChem_id": "NA","DrugBank_id": "NA"}
